 |
市場調查報告書
商品編碼
1081218
癌症患者門診輸液市場規模/份額/行業分析2022-2030：產品/用途/療法/模式/區域前景/增長潛力/競爭市場份額/預測Outpatient Oncology Infusion Market Size, Share and Industry Analysis Report by Product, Application, By Therapy and Mode (Intramuscular, Intravenous, Subcutaneous), Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022- 2030 |
||||||
價格
由於癌症患者人數的增加和全球對癌症治療研發的興趣日益濃厚，預計到 2030 年全球癌症患者門診輸液市場將大幅增長。
按產品劃分，IV Cannula 部門將在 2021 年產生約 40 億美元的收入。這主要是由於在臨床試驗醫療過程中越來越多地採用 IV 插管進行藥物注射或血液樣本採集。在全球癌症發病率不斷上升的背景下，到 2021 年，激素治療行業的銷售額將超過 60 億美元。提高患者和醫生對替代癌症治療（如激素治療）益處的認識也是行業增長的主要增長動力。
本報告調查了全球癌症患者門診輸液市場，定義和概述了市場，分析了新型冠狀病毒感染（COVID-19）等市場影響因素，並對市場規模進行了變化和預測。類別/地區/主要國家、競爭環境、主要公司概況等。
目錄
第一章調查方法
第2章執行摘要
第3章癌症患者門診輸液行業的思考
- 行業分類
- 產業情況
- 行業影響因素
- 生長因子
- 潛在風險和挑戰
- 增長潛力分析
- COVID-19：影響分析
- 波特分析
- 競爭形勢
- PESTEL 分析
第 4 章癌症患者門診輸液市場：按產品分類
- 主要趨勢
- 輸液泵
- 靜脈組
- IV 插管
- 無針接頭
第 5 章癌症患者門診輸液市場：按用途
- 主要趨勢
- 肺癌
- 肝癌
- 乳腺癌
- 前列腺癌
- 其他
第 6 章癌症患者門診輸液市場：按治療方法
- 主要趨勢
- 化療
- 靶向治療
- 免疫療法
- 激素療法
第7章癌症患者門診輸液市場：按模式
- 主要趨勢
- 肌肉注射 (IM)
- 靜脈注射 (IV)
- 皮下
- 其他
第 8 章癌症患者門診輸液市場：按地區劃分
- 主要趨勢
- 北美
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東/非洲
第 9 章公司簡介
- 策略儀表板
- B. Braun Melsungen AG
- Baxter
- Becton, Dickinson, and Company
- Fresenius Kabi
- ICU Medical, Inc
- IRadimed Corporation
- Nipro Corporation
- Terumo Corporation
- Smiths Medical
- Medtronic PLC
- Roche Diagnostics
- Teleflex, Inc.,
Product Code: 5268
The global outpatient oncology infusion market is expected to register commendable growth by 2030, due in part to the rising prevalence of cancer cases and growing investment interest towards R&D for cancer treatment worldwide.
Outpatient oncology infusion therapy is rapidly emerging as a major component of modern cancer treatment protocols. Infusion therapy refers to procedures where medicine is administered directly into the bloodstream of the patient to shrink or curb the growth of cancer cells.
Outpatient infusion therapies for cancer treatment encompass various services, including hormone therapy, immunotherapy, chemotherapy, and blood transfusions, as well as other infusion treatments the patient may require, like antibiotics, pain medication, and hydration fluids.
The global outpatient oncology infusion market is bifurcated in terms of product, application, therapy, mode, and region.
With respect to product, the outpatient oncology infusion industry is further classified into intravenous sets, infusion pumps, needleless connectors, and IV cannulas.
Of these, the IV cannulas segment registered revenues worth nearly $4 billion in 2021. This was credited largely to a rising adoption of IV cannulas for the infusion of medication or collection of blood samples in investigational medical processes.
Based on application, the outpatient oncology infusion market is segregated into liver cancer, lung cancer, prostate cancer, breast cancer, and others.
The liver cancer segment held a 3.9% share of the overall market in 2021, given the rapid rise in the prevalence of liver cancer, as well as the escalating demand for infusion therapies like targeted therapy or immunotherapy.
In February 2022, for instance, oncologists and surgeons at Penn Medicine's Department of Surgery used adjuvant hepatic artery infusion chemotherapy along with systemic chemotherapy, in order to treat unresectable CLMs (colorectal liver metastases) or mitigate the risk of recurrence among individuals with resected CLMs.
From a therapy perspective, the outpatient oncology infusion industry is categorized into targeted therapy, immunotherapy, chemotherapy, and hormonal therapy. The hormonal therapy segment recorded a remuneration of over $6 billion in 2021, driven by the growing prevalence of cancer across the globe.
Additionally, rising awareness among patients and physicians regarding the benefits of alternative cancer treatments like hormone therapy is a major driver propelling industry growth.
With regard to mode, the overall outpatient oncology infusion market is divided into Intravenous (IV), Intramuscular (IM), Subcutaneous, and other.
In 2021, the intravenous (IV) segment accounted for almost 30.6% of the overall market share due to the rising occurrence of lung cancer, wherein IV solutions act as the primary source of energy for the patients. In addition, increasing rollout of intravenous (IV) products has also elevated the industry outlook.
In March 2022, for instance, a new therapy was approved by the FDA for the treatment of advanced prostate cancer metastasizing within the body. Known as Pluvicto, the therapy was designed to be administered via intravenous infusion, to identify and destroy tumors too small to be noticed through conventional medical imaging techniques.
On the regional front, the Latin America outpatient oncology infusion industry is poised to register a 12.2% CAGR through the forecast time period. This growth is mainly credited to technological advancements in the regional medical domain, and strong market players focus on developing novel and sophisticated outpatient oncology infusion therapies.
Table of Contents
Chapter 1 Methodology
- 1.1 Methodology
- 1.2 Market definitions
- 1.3 Forecast parameters
- 1.4 Data sources
- 1.4.1 Secondary
- 1.4.1.1 Paid sources
- 1.4.1.2 Unpaid sources
- 1.4.2 Primary
- 1.4.1 Secondary
Chapter 2 Executive Summary
- 2.1 Outpatient oncology infusion industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Application trends
- 2.1.4 Therapy trends
- 2.1.5 Mode trends
- 2.1.6 Regional trends
Chapter 3 Outpatient Oncology Infusion Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2030
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Recent technological advancements in infusion pumps
- 3.3.1.2 Rising prevalence of cancer across the globe
- 3.3.1.3 Surging government initiatives for cancer awareness
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 High costs of cancer therapies
- 3.3.2.2 Safety concern associated with the cancer therapy
- 3.3.1 Growth drivers
- 3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By application
- 3.4.3 By therapy
- 3.4.4 By mode
- 3.5 COVID-19 impact analysis
- 3.6 Porter's analysis
- 3.7 Competitive landscape, 2021
- 3.8 PESTEL analysis
Chapter 4 Outpatient Oncology Infusion Market, By Product
- 4.1 Key segment trends
- 4.2 Infusion Pumps
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3 Intravenous Sets
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.4 IV Cannulas
- 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.5 Needleless Connectors
- 4.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Outpatient Oncology Infusion Market, By Application
- 5.1 Key segment trends
- 5.2 Lung Cancer
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.3 Liver Cancer
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.4 Breast Cancer
- 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.5 Prostate Cancer
- 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.6 Other
- 5.6.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Outpatient Oncology Infusion Market, By Therapy
- 6.1 Key segment trends
- 6.2 Chemotherapy
- 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.3 Targeted Therapy
- 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.4 Immunotherapy
- 6.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.5 Hormonal Therapy
- 6.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Outpatient Oncology Infusion Market, By Mode
- 7.1 Key segment trends
- 7.2 Intramuscular (IM)
- 7.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.3 Intravenous (IV)
- 7.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.4 Subcutaneous
- 7.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.5 Others
- 7.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 8 Outpatient Oncology Infusion Market, By Region
- 8.1 Key regional trends
- 8.2 North America
- 8.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.2.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.2.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.2.5 Market size, by mode, 2017 - 2030 (USD Million)
- 8.2.6 U.S.
- 8.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.2.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.2.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.2.7 Canada
- 8.2.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.2.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.2.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.2.7.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.3 Europe
- 8.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.3.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.3.5 Market size, by mode, 2017 - 2030 (USD Million)
- 8.3.6 Germany
- 8.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.3.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.3.7 UK
- 8.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.3.7.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.3.8 France
- 8.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.8.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.3.8.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.3.9 Spain
- 8.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.3.9.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.3.9.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.4 Asia Pacific
- 8.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.4.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.4.5 Market size, by mode, 2017 - 2030 (USD Million)
- 8.4.6 Japan
- 8.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.4.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.4.7 China
- 8.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.4.7.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.4.8 India
- 8.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.8.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.4.8.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.4.9 Australia
- 8.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.4.9.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.4.9.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.5 Latin America
- 8.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.5.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.5.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.5.5 Market size, by mode, 2017 - 2030 (USD Million)
- 8.5.6 Brazil
- 8.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.5.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.5.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.5.7 Mexico
- 8.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.5.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.5.7.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.6 MEA
- 8.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.6.2 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.3 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.4 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.6.5 Market size, by mode, 2017 - 2030 (USD Million
- 8.6.6 South Africa
- 8.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.6.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.6.6.4 Market size, by mode, 2017 - 2030 (USD Million)
- 8.6.7 Saudi Arabia
- 8.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
- 8.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
- 8.6.7.3 Market size, by therapy, 2017 - 2030 (USD Million)
- 8.6.7.4 Market size, by mode, 2017 - 2030 (USD Million)
Chapter 9 Company Profiles
- 9.1 Strategy dashboard, 2021
- 9.2 B. Braun Melsungen AG
- 9.2.1 Business overview
- 9.2.2 Financial data
- 9.2.3 Product landscape
- 9.2.4 Strategic outlook
- 9.2.5 SWOT analysis
- 9.3 Baxter
- 9.3.1 Business overview
- 9.3.2 Financial data
- 9.3.3 Product landscape
- 9.3.4 Strategic outlook
- 9.3.5 SWOT analysis
- 9.4 Becton, Dickinson, and Company
- 9.4.1 Business overview
- 9.4.2 Financial data
- 9.4.3 Product landscape
- 9.4.4 Strategic outlook
- 9.4.5 SWOT analysis
- 9.5 Fresenius Kabi
- 9.5.1 Business overview
- 9.5.2 Financial data
- 9.5.3 Product landscape
- 9.5.4 Strategic outlook
- 9.5.5 SWOT analysis
- 9.6 ICU Medical, Inc
- 9.6.1 Business overview
- 9.6.2 Financial data
- 9.6.3 Product landscape
- 9.6.4 Strategic outlook
- 9.6.5 SWOT analysis
- 9.7 IRadimed Corporation
- 9.7.1 Business overview
- 9.7.2 Financial data
- 9.7.3 Product landscape
- 9.7.4 Strategic outlook
- 9.7.5 SWOT analysis
- 9.8 Nipro Corporation
- 9.8.1 Business overview
- 9.8.2 Financial data
- 9.8.3 Product landscape
- 9.8.4 Strategic outlook
- 9.8.5 SWOT analysis
- 9.9 Terumo Corporation
- 9.9.1 Business overview
- 9.9.2 Financial data
- 9.9.3 Product landscape
- 9.9.4 Strategic outlook
- 9.9.5 SWOT analysis
- 9.10 Smiths Medical
- 9.10.1 Business overview
- 9.10.2 Financial data
- 9.10.3 Product landscape
- 9.10.4 Strategic outlook
- 9.10.5 SWOT analysis
- 9.11 Medtronic PLC
- 9.11.1 Business overview
- 9.11.2 Financial data
- 9.11.3 Product landscape
- 9.11.4 Strategic outlook
- 9.11.5 SWOT analysis
- 9.12 Roche Diagnostics
- 9.12.1 Business overview
- 9.12.2 Financial data
- 9.12.3 Product landscape
- 9.12.4 Strategic outlook
- 9.12.5 SWOT analysis
- 9.13 Teleflex, Inc.,
- 9.13.1 Business overview
- 9.13.2 Financial data
- 9.13.3 Product landscape
- 9.13.4 Strategic outlook
- 9.13.5 SWOT analysis
Data Tables
- TABLE 1 Outpatient oncology infusion industry 360 degree synopsis, 2017-2030
- TABLE 2 Global outpatient oncology infusion market, 2017-2030 (USD Million)
- TABLE 3 Global outpatient oncology infusion market, by product, 2017-2030 (USD Million)
- TABLE 4 Global outpatient oncology infusion market, by application, 2017-2030 (USD Million)
- TABLE 5 Global outpatient oncology infusion market, by therapy, 2017-2030 (USD Million)
- TABLE 6 Global outpatient oncology infusion market, by mode, 2017-2030 (USD Million)
- TABLE 7 Global outpatient oncology infusion market, by region, 2017-2030 (USD Million)
- TABLE 8 Industry impact forces
- TABLE 9 Infusion pumps market size, by region, 2017-2030 (USD Million)
- TABLE 10 Intravenous sets market size, by region, 2017-2030 (USD Million)
- TABLE 11 IV cannulas market size, by region, 2017-2030 (USD Million)
- TABLE 12 Needleless connectors market size, by region, 2017-2030 (USD Million)
- TABLE 13 Lung cancer market size, by region, 2017-2030 (USD Million)
- TABLE 14 Liver cancer market size, by region, 2017-2030 (USD Million)
- TABLE 15 Breast cancer market size, by region, 2017-2030 (USD Million)
- TABLE 16 Prostate cancer market size, by region, 2017-2030 (USD Million)
- TABLE 17 Others market size, by region, 2017-2030 (USD Million)
- TABLE 18 Chemotherapy market size, by region, 2017-2030 (USD Million)
- TABLE 19 Targeted therapy market size, by region, 2017-2030 (USD Million)
- TABLE 20 Immunotherapy market size, by region, 2017-2030 (USD Million)
- TABLE 21 Hormonal therapy market size, by region, 2017-2030 (USD Million)
- TABLE 22 Intramuscular (IM) market size, by region, 2017-2030 (USD Million)
- TABLE 23 Intravenous (IV) market size, by region, 2017-2030 (USD Million)
- TABLE 24 Others market size, by region, 2017-2030 (USD Million)
- TABLE 25 North America outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
- TABLE 26 North America outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
- TABLE 27 North America outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 28 North America outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 29 North America outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 30 North America outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 31 U.S. outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 32 U.S. outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 33 U.S. outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 34 U.S. outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 35 Canada outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 36 Canada outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 37 Canada outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 38 Canada outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 39 Europe outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
- TABLE 40 Europe outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
- TABLE 41 Europe outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 42 Europe outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 43 Europe outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 44 Europe outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 45 Germany outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 46 Germany outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 47 Germany outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 48 Germany outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 49 UK outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 50 UK outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 51 UK outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 52 UK outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 53 France outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 54 France outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 55 France outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 56 France outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 57 Spain outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 58 Spain outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 59 Spain outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 60 Spain outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 61 Italy outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 62 Italy outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 63 Italy outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 64 Italy outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 65 Asia Pacific outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
- TABLE 66 Asia Pacific outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 67 Asia Pacific outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 68 Asia Pacific outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 69 Asia Pacific outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 70 Japan outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 71 Japan outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 72 Japan outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 73 Japan outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 74 China outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 75 China outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 76 China outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 77 China outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 78 India outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 79 India outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 80 India outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 81 India outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 82 Australia outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 83 Australia outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 84 Australia outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 85 Australia outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 86 Latin America outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
- TABLE 87 Latin America outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 88 Latin America outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 89 Latin America outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 90 Latin America outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 91 Brazil outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 92 Brazil outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 93 Brazil outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 94 Brazil outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 95 Mexico outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 96 Mexico outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 97 Mexico outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 98 Mexico outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 99 MEA outpatient oncology infusion market size, by country, 2017-2030 (USD Million)
- TABLE 100 MEA outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 101 MEA outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 102 MEA outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 103 MEA outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 104 South Africa outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 105 South Africa outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 106 South Africa outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 107 South Africa outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 108 Saudi Arabia outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 109 Saudi Arabia outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 110 Saudi Arabia outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 111 Saudi Arabia outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
- TABLE 112 UAE outpatient oncology infusion market size, by product, 2017-2030 (USD Million)
- TABLE 113 UAE outpatient oncology infusion market size, by application, 2017-2030 (USD Million)
- TABLE 114 UAE outpatient oncology infusion market size, by therapy, 2017-2030 (USD Million)
- TABLE 115 UAE outpatient oncology infusion market size, by mode, 2017-2030 (USD Million)
Charts & Figures
- FIG. 1 Industry segmentation
- FIG. 2 Global outpatient oncology infusion market, 2017 - 2030 (USD Million)
- FIG. 3 Growth potential analysis, by product
- FIG. 4 Growth potential analysis, by application
- FIG. 5 Growth potential analysis, by therapy
- FIG. 6 Growth potential analysis, by mode
- FIG. 7 Porter's analysis
- FIG. 8 PESTEL analysis
- FIG. 9 Key segment trends, by product
- FIG. 10 Key segment trends, by application
- FIG. 11 Key segment trends, by therapy
- FIG. 12 Key segment trends, by mode
- FIG. 13 Key regional trends
- FIG. 14 Strategy dashboard, 2021
